
|Articles|September 24, 2015
Lecia V. Sequist Provides an Overview of T790M Mutations in NSCLC
Author(s)Lecia V. Sequist
Lecia V. Sequist, associate professor of medicine, Massachusetts General Hospital, provides an overview of T790M, a mutation in the epidermal growth factor receptor (EGFR) gene.
Advertisement
Lecia V. Sequist, associate professor of medicine, Massachusetts General Hospital, provides an overview of T790M, a mutation in the epidermal growth factor receptor (EGFR) gene. T790M is the primary cause of treatment resistance in EGFR-positive patients with non-small cell lung cancer (NSCLC).
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Doctor Outlines Cervical Cancer Care, Side Effects, HPV Prevention
2
FDA to Review New Drug Combo for Previously Treated Metastatic Colorectal Cancer
3
Erleada Shows Survival Advantage in Real-World Study of Metastatic Prostate Cancer
4
Expert Insights: FDA Approval of Lymphir for Cutaneous T-Cell Lymphoma
5




